基本信息
views: 41
Career Trajectory
Bio
Maria Teresa Cruz (MT Cruz) has a degree in Pharmaceutical Sciences (1991) from the University of Lisbon, a master in Drug Technologies (1996) and a PhD in Pharmacology (2004) from the University of Coimbra. She is associate professor at the Faculty of Pharmacy and Group Leader at the Center for Neuroscience and Cell Biology at the University of Coimbra (Cell Signaling and Metabolism in Disease) and Principal Investigator of the research line Innate Immunity in inflammation-related diseases.
MT Cruz has been dedicated for approximately two decades to the study of the immunobiology of inflammatory processes with a special focus in dendritic cells and macrophages. MT Cruz holds the European Registered Toxicologist (ERT) title, awarded by EUROTOX (Federation of European Toxicologists and European Societies of Toxicology), since 2018. She has participated in national and international funded projects (43 projects), being the researcher responsible for 19, namely from the European Union 7th Framework Programme, John Hopkins, USA, Cosmetics Europe, Lierac and Vichy. She published 4 international patents, 6 book chapters and 185 articles in SCI indexed journals, supervised or co-supervised 19 PhD students, 24 master thesis and 3 pos-docs presenting an h-index of 36 with 7,476 citations, according to the Web of Science.
MT Cruz is a regular reviewer of I&D projects from Fundação para a Ciência e Tecnologia, Netherlands Organisation for Scientific Research, French National Research Agency, Alzheimer's Association Research Fellowship Program, Estonian Research Council, Science Fund of the Republic of Serbia, External Expert for COST proposals evaluation and National Centre of Science and Technology Evaluation from Cazaquistão.
At the level of knowledge transfer and valorisation, the creation of a spin-off from the UC stands out, Toxfinder, which received several entrepreneurship awards, highlighting her participation in patents and activities in the provision of specialized services to national and international entities, namely Cosmetics Europe, a European entity that represents around 40 of the largest companies in the world of cosmetic products. Maria Teresa Cruz participated in the design and creation of a Pilot Production Unit for Cell Therapy, UpCells laboratory, resulting from a partnership between UC and the pharmaceutical industry Tecnimede, fulfilling all the requirements for the preparation and handling of cellular products for clinical application according to Good Manufacturing Practice (GMP).
In terms of pedagogical activity, MT Cruz teaches several curricular units of the Integrated Master in Pharmaceutical Sciences, Degree in Bioanalytical Sciences, Degree in Biomedical Pharmacy and Degree in Medicinal Chemistry, taught at the Faculty of Pharmacy. She teaches, or taught, Pharmacology, Histology and Human Embriology, Cell Biology, Molecular Biology, Immunology, Pathophysiology, Anatomy and Human Physiology, Pre-Clinical Drug Development and Pharmacological Screening. At the postgraduate level, MT Cruz has collaborated in several master's programs taught at UC (Applied Pharmacology, Pharmaceutical Biotechnology, Biomedical Research, Medicinal Chemistry), at the State University of São Paulo (UNESP), as well as in several doctoral programs at the University of Coimbra.
Research Interests
Papers共 240 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
International Immunopharmacology (2024): 111471-111471
Miguel F. Galrinho,Lisete M. Silva,Guido R. Lopes, Bernardo A.C. Ferreira,Sara A. Valente,Isabel Ferreira,Benedita A. Pinheiro,Angelina S. Palma,Dmitry V. Evtuguin,José A. Lopes da Silva, Margarida Almeida,Paula Ferreira,
Carbohydrate Polymers (2024): 122268-122268
Ane Arregi,Oscar Vegas,Aitana Lertxundi, Ana Silva,Isabel Ferreira, Ainhoa Bereziartua,Maria Teresa Cruz,Nerea Lertxundi
Environmental Science and Pollution Researchpp.1-20, (2024)
INTERNATIONAL IMMUNOPHARMACOLOGY (2024)
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2024): 123996-123996
International immunopharmacology (2024): 111471-111471
biorxiv(2024)
Drug Discovery Todayno. 7 (2024): 104052-104052
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn